Meta Description: Explore Huperzia Serrata Extract (1%–2% Huperzine A) — a potent acetylcholinesterase inhibitor backed by decades of neuroscience research. Applications in nootropic supplements, cognitive health, and Alzheimer's research. Greensky Bio, your certified botanical extract partner.
Meta Keywords: Huperzia serrata extract, Huperzine A, acetylcholinesterase inhibitor, nootropic extract, cognitive health supplement, memory enhancement natural, Alzheimer research compound, plant extract manufacturer, China Huperzine A supplier, Qian Ceng Tai extract
URL Slug: /plant_extract/huperzia-serrata-extract-huperzine-a-cognitive-health-guide.html
Target Keywords:
Primary: "Huperzia serrata extract", "Huperzine A extract"
Secondary: "natural acetylcholinesterase inhibitor", "nootropic plant extract", "memory support supplement"
Long-tail: "Huperzine A 1% extract supplier", "Huperzia serrata for cognitive function", "Huperzine A bulk powder manufacturer"
Huperzia serrata (Huperzia serrata (Thunb.) Trev.), known in traditional Chinese medicine as "Qian Ceng Tai" (千层塔 — literally "thousand-layer pagoda"), is a club moss species that has been used in Chinese herbal medicine for centuries to treat fever, inflammation, and various neurological conditions. Its discovery as a rich natural source of Huperzine A — a potent and selective acetylcholinesterase (AChE) inhibitor — transformed this modest fern-like plant into one of the most important botanicals in modern neuroscience research. Since its isolation and pharmacological characterization in the 1980s by Chinese scientists, Huperzine A has been approved in China as a prescription treatment for Alzheimer's disease and has attracted intense global research interest for its potential in cognitive enhancement, neuroprotection, and age-related memory decline.
Hangzhou Greensky Biological Tech Co., Ltd — a professional natural plant extract manufacturer established in 2004 — offers standardized Huperzia Serrata Extract with verified Huperzine A content, produced under strict quality control and backed by ISO22000, BRCGS, Ecocert Organic, and SGS-GMP certifications.
Huperzia Serrata Extract is a concentrated preparation derived from the whole herb (aerial parts and stems) of Huperzia serrata (Thunb.) Trev., a perennial epiphytic club moss belonging to the Lycopodiaceae family. This species grows in shaded, humid forest environments at elevations of 800–2,500 meters across Central and Southern China, Japan, India, and Southeast Asia.
| Item | Details |
|---|---|
| Latin Name | Huperzia serrata (Thunb.) Trev. |
| Family | Lycopodiaceae (Club moss family) |
| Common Names | Qian Ceng Tai (千层塔), Firmoss, Snake Moss |
| Main Growing Regions | China (Zhejiang, Fujian, Jiangxi, Hunan, Sichuan), Japan, India, Southeast Asia |
| Extraction Part | Whole herb (aerial parts and stems) |
| Appearance | Yellowish-brown to brown fine powder |
| Odor | Mild, characteristic herbal odor |
| Compound | Role | Significance |
|---|---|---|
| Huperzine A | Lycopodium alkaloid | Primary active marker; potent, reversible AChE inhibitor (IC50 ≈ 0.3–0.5 μM) |
| Huperzine B | Lycopodium alkaloid | Structurally related but significantly less potent AChE inhibitor |
| Huperzine C–H | Minor alkaloids | Contribute to overall alkaloid profile; research-grade interest |
| Serratinine | Lycopodium alkaloid | Secondary alkaloid with distinct pharmacological properties |
| Specification | Standard |
|---|---|
| Huperzine A | 0.5%, 1.0%, 1.5%, 2.0% (HPLC) |
| Total Alkaloids | 2%–5% |
| Loss on Drying | ≤5.0% |
| Ash Content | ≤5.0% |
| Heavy Metals | ≤10 ppm |
| Pesticide Residues | Compliant with EU/US pharmacopoeia limits |
| Microbiological | Total plate count <10,000 CFU/g; E. coli negative; Salmonella negative |
Cultivated Harvesting: Huperzia serrata is sourced from GAP-certified cultivated farms in Zhejiang and Fujian provinces, ensuring sustainable supply and consistent alkaloid content (wild harvesting is restricted due to conservation concerns).
Cleaning & Drying: Whole herb is carefully cleaned and dried at controlled temperatures (≤45°C) to preserve alkaloid integrity.
Acid-Alkali Extraction: Optimized acid-base extraction process selectively isolates alkaloid fractions from the plant matrix.
Purification: Multi-step purification including acid-base partitioning, column chromatography, and recrystallization to achieve standardized Huperzine A concentrations.
Drying & Milling: Vacuum drying followed by precision milling to produce uniform fine powder (80–200 mesh).
Quality Testing: HPLC quantification of Huperzine A, full alkaloid profiling, heavy metals screening, pesticide residue testing, and complete microbiological analysis.
| Test Item | Result | Specification |
|---|---|---|
| Appearance | Yellowish-brown fine powder | Complies |
| Huperzine A (HPLC) | 1.05% | ≥1.0% |
| Huperzine B (HPLC) | 0.32% | — |
| Total Alkaloids | 3.8% | — |
| Loss on Drying | 3.1% | ≤5.0% |
| Ash | 4.2% | ≤5.0% |
| Heavy Metals | <5 ppm | ≤10 ppm |
| Lead | <0.5 ppm | ≤2.0 ppm |
| Arsenic | <0.3 ppm | ≤1.0 ppm |
Huperzine A's most well-characterized mechanism is its potent and reversible inhibition of acetylcholinesterase (AChE), the enzyme responsible for breaking down acetylcholine in the synaptic cleft:
Selective AChE Inhibition: Huperzine A binds to both the catalytic anionic site and the peripheral anionic site of AChE, providing a dual-action inhibition mechanism that is more comprehensive than many synthetic AChE inhibitors (PubMed: 12593911).
Blood-Brain Barrier Penetration: Unlike some synthetic cholinesterase inhibitors, Huperzine A readily crosses the blood-brain barrier, achieving therapeutic concentrations in the central nervous system (PubMed: 9822705).
Longer Duration of Action: Huperzine A has a longer half-life (~5–6 hours) compared to physostigmine (~30 minutes), allowing for less frequent dosing and more stable therapeutic levels (PubMed: 12593911).
Clinical Evidence: A meta-analysis of randomized controlled trials involving over 1,000 patients found that Huperzine A significantly improved cognitive function scores (MMSE, ADAS-cog), activities of daily living, and clinical global impression in patients with Alzheimer's disease and vascular dementia (PubMed: 23076907).
Huperzine A's therapeutic potential extends well beyond cholinergic enhancement:
NMDA Receptor Antagonism: Huperzine A acts as a non-competitive antagonist at NMDA (N-methyl-D-aspartate) receptors, protecting neurons against excitotoxicity — a key pathological mechanism in Alzheimer's disease and other neurodegenerative conditions (PubMed: 17659840).
Anti-Apoptotic Activity: Huperzine A prevents neuronal apoptosis by inhibiting caspase-3 activation and modulating Bcl-2/Bax protein expression, protecting cells from programmed cell death (PubMed: 18325508).
Oxidative Stress Reduction: Huperzine A reduces reactive oxygen species (ROS) generation and lipid peroxidation in neuronal tissue, contributing to its neuroprotective profile (PubMed: 20600137).
Microglial Activation Suppression: Huperzine A suppresses the activation of microglia — the brain's resident immune cells — reducing the production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and nitric oxide (NO) in neuroinflammatory models (PubMed: 22425657).
Amyloid-Beta Interaction: Research suggests Huperzine A may interfere with amyloid-beta aggregation and reduce beta-amyloid-induced neurotoxicity, addressing one of the core pathological features of Alzheimer's disease (PubMed: 18440285).
Memory & Learning: Beyond its therapeutic applications in dementia, Huperzine A has shown promise for cognitive enhancement in healthy individuals. Studies demonstrate improvements in working memory, attention, and information processing speed (PubMed: 17659840).
Nootropic Applications: The nootropic community has embraced Huperzine A as a cognitive enhancer, with users reporting improved focus, mental clarity, and memory retention. Typical nootropic dosing ranges from 50–200 mcg of Huperzine A per day.
Cycling Protocol: Due to its mechanism of AChE inhibition, most experts recommend cycling Huperzine A (e.g., 5 days on, 2 days off) to prevent receptor adaptation and maintain efficacy.
Brain Health Capsules: Huperzine A is the centerpiece of premium cognitive health supplements, typically dosed at 50–200 mcg per serving. Combined with Bacopa monnieri, Ginkgo biloba, phosphatidylserine, and Omega-3 DHA for comprehensive brain support.
Nootropic Stacks: Popular in the nootropic community as part of multi-ingredient cognitive enhancement formulations, often paired with racetams, choline donors (Alpha-GPC, CDP-Choline), and other adaptogens.
Senior Cognitive Support: Specifically formulated products targeting age-related cognitive decline, memory support, and mental sharpness in adults over 50.
Alzheimer's Disease Treatment: Huperzine A is approved in China as a prescription drug for Alzheimer's disease treatment (brand name: Shuang Yiping / 双益平).
Clinical Trials: Ongoing research explores Huperzine A's potential in vascular dementia, Parkinson's disease, schizophrenia-associated cognitive impairment, and myasthenia gravis.
Drug Development Platform: The unique alkaloid structure of Huperzine A serves as a lead compound for developing next-generation AChE inhibitors with improved pharmacological profiles.
Cognitive Energy Drinks: Emerging category of functional beverages combining Huperzine A with caffeine, L-Theanine, and B-vitamins for focused mental energy.
Gummy Supplements: Water-soluble Huperzine A formulations incorporated into gummy and chewable supplement formats for consumer-friendly delivery.
Canine Cognitive Dysfunction: Huperzine A is increasingly used in veterinary supplements for canine cognitive dysfunction syndrome (CCDS), the dog equivalent of Alzheimer's disease.
Equine Performance: Research explores potential applications in equine neurology and performance enhancement.
Correct species identification is critical. Huperzia serrata must be distinguished from related species such as Huperzia lucidula (North American firmoss), which has a different alkaloid composition. Quality suppliers use HPLC fingerprinting and TLC analysis to confirm species identity and alkaloid profile authenticity.
Huperzine A is active at microgram-level dosing. Accurate quantification using validated HPLC methods with appropriate detection limits (UV at 310 nm or mass spectrometry) is essential. Suppliers who cannot provide batch-specific HPLC chromatograms should be avoided.
Wild Huperzia serrata populations are under conservation pressure in many regions. Responsible suppliers source from GAP-certified cultivated farms with documented sustainable practices. China's Ministry of Agriculture regulates the cultivation and harvest of this species — compliant sourcing is non-negotiable.
Given the potent biological activity of Huperzine A, purity standards are paramount:
Heavy metals testing (Pb, As, Cd, Hg) using ICP-MS
Pesticide residue screening — EU multi-residue method (500+ compounds)
Solvent residue analysis — ICH Q3C compliance
Microbiological testing — full panel including aflatoxins
For nootropic and supplement manufacturers, the ability to deliver precise, consistent Huperzine A concentrations across batches is critical. Leading suppliers provide tight specification ranges (e.g., 1.0% ± 0.1%) with full batch-to-batch documentation.
As a professional natural plant extract manufacturer with over 20 years of experience, Hangzhou Greensky Biological Tech Co., Ltd provides premium Huperzia Serrata Extract with the following advantages:
Verified Potency: Every batch analyzed by HPLC for precise Huperzine A quantification (0.5%–2.0% specifications available) with full chromatographic documentation.
Sustainable Cultivation: Raw materials sourced exclusively from GAP-certified cultivated farms in Zhejiang and Fujian provinces, ensuring legal compliance and environmental sustainability.
Advanced Alkaloid Extraction: Proprietary acid-base extraction and purification technology optimized for maximum Huperzine A recovery and purity.
R&D Capability: In-house analytical laboratory equipped with HPLC, GC-MS, and ICP-MS, staffed by experienced phytochemistry researchers.
Full Certifications: ISO22000, BRCGS, Ecocert Organic, Kosher, Halal, and SGS-GMP certified production facility.
Customized Solutions: Flexible specifications, custom alkaloid profiles, and private label support for B2B partners in the nootropic and cognitive health markets.
Regulatory Support: Comprehensive documentation packages including Certificates of Analysis, safety data sheets, allergen statements, and regulatory guidance for target market entry.
Huperzia Serrata Extract, standardized for Huperzine A content, represents one of the most potent and scientifically validated natural compounds for cognitive health support. With a well-established mechanism of action (dual-site AChE inhibition), documented neuroprotective effects, and growing applications spanning nootropic supplements, pharmaceutical research, and veterinary care, the demand for high-quality, standardized Huperzine A extract continues to grow globally.
The unique challenge — and opportunity — in this market lies in sourcing from a manufacturer that combines analytical precision, sustainable practices, and regulatory compliance, ensuring every microgram of Huperzine A delivers consistent, reliable performance.
Ready to source premium Huperzia Serrata Extract?
Contact us today for competitive pricing, detailed specifications, and free sample requests.
Our technical team can provide customized Huperzine A specifications tailored to your application — from 0.5% extract for broad-spectrum formulations to 2.0% high-potency material for precision nootropic products.
Request complete documentation: Certificates of Analysis with HPLC chromatograms, third-party test reports, and regulatory support packages.
Hangzhou Greensky Biological Tech Co., Ltd — Science-backed botanical extracts for cognitive health and beyond, since 2004.
2026-08-26
2026-08-26
2026-08-26
2026-08-26
2026-08-26
2026-08-26
2026-08-26
2026-08-26
2026-08-26
2026-08-26